Enterprise Value
1.589B
Cash
651.8M
Avg Qtr Burn
-12.88M
Short % of Float
17.37%
Insider Ownership
9.45%
Institutional Own.
96.65%
Qtr Updated
03/31/24
Drug Pipeline
Powered by
![](/BPIQ_Pill.png)
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|---|---|
JANX008 (EGFR-TRACTr) Details Cancer, Solid tumor/s | Phase 1 Data readout | |
JANX007 (PSMA-TRACTr) Details Castration-resistant prostate cancer, Cancer, Prostate cancer | Phase 1 Data readout |